GT Biopharma, Inc. (GTBP) Institutional Ownership & Insider Trading
59 institutions reported holding GT Biopharma, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GTBPGT Biopharma, Inc.Follow GTBP — free
—
Price chart with a free account
- Market cap
- 9.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters59 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +21.4%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 59 | 2 | +21.4% | 7 | 18 | 6 | 5 |
| Mar 26 | 41 | 2 | +94.2% | 7 | 12 | 3 | 9 |
| Dec 25 | 38 | 0 | +26.0% | 3 | 20 | 8 | 5 |
| Sep 25 | 20 | 0 | +88.4% | 4 | 3 | 4 | 2 |
| Jun 25 | 21 | 0 | +90.5% | 7 | 3 | 2 | 3 |
| Mar 25 | 20 | 0 | +14.1% | 2 | 3 | 5 | 0 |
| Dec 24 | 17 | 0 | -4.2% | 3 | 3 | 2 | 2 |
| Sep 24 | 15 | 0 | -11.8% | 1 | 0 | 5 | 0 |
GT Biopharma, Inc. — questions
- Who owns GT Biopharma, Inc. stock?
- 59 institutions reported GT Biopharma, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: VANGUARD CAPITAL MANAGEMENT LLC (20.9%), GEODE CAPITAL MANAGEMENT, LLC (14.8%), VANGUARD FIDUCIARY TRUST CO (12.5%).
Every figure on this page comes from GT Biopharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.